An error was made in the news article, “SSRI ads questioned.”1 Dr. Wayne Goodman, Chair of the US Food and Drug Administration Psychopharmacologic Drugs Advisory Committee does not support prohibiting advertisements making certain claims for selective serotonin reuptake inhibitors.